Evidence-based pancreatology 2018 (review of research results on diseases and exocrine pancreatic insufficiency)
PDF (Русский)
DOCX

Keywords

pancreatology, chronic pancreatitis, exocrine pancreatic insufficiency, studies, steatorrhea, diabetes mellitus, enzyme replacement therapy

How to Cite

Gubergrits, N. B., Byelyayeva, N. V., Klochkov, A. Y., Lukashevich, G. M., Fomenko, P. G., & Berezhnaya, E. V. (2019). Evidence-based pancreatology 2018 (review of research results on diseases and exocrine pancreatic insufficiency). Herald of Pancreatic Club, 43(2), 4-14. https://doi.org/10.33149/vkp.2019.02.01

Abstract views: 70
PDF Downloads: 47 PDF Downloads: 16

Abstract

The article presents a detailed review of the research results in the field of pancreatology published in 2018. Certain parts of the review are devoted to the pathogenesis, diagnostics, course of pancreatitis, its treatment, as well as autoimmune, hereditary pancreatitis, pancreatic pathology in children, as well as treatment.

In studying the pathogenesis of pancreatitis, attention is paid to genetic markers of pancreatitis along with a role of bacterial overgrowth syndrome in the small intestine, both in terms of worsening of the course of pancreatitis and the lack of effectiveness of enzyme replacement therapy. The study of the role of alcohol abuse and smoking in the pathogenesis of pancreatic pathology is still in progress.

Diagnostics is going on. Endosonography remains the most informative method.

A number of studies have been devoted to the studying of exocrine and endocrine pancreatic insufficiency both upon pancreatitis, pancreatic tumors, and in functional dyspepsia and HIV infection.

Autoimmune pancreatitis is increasingly being diagnosed, a number of studies are devoted to its diagnostics and treatment.

Pancreatic diseases in children develop mainly on the background of genetic predisposition, while functional pancreatic insufficiency occurs in adult patients.

The study of the peculiarities of the effect of enzyme replacement therapy continues. The immediate and remote results of the surgical treatment of pancreatic pathology are assessed.

https://doi.org/10.33149/vkp.2019.02.01
PDF (Русский)
DOCX

References

1. Губергриц Н. Б., Беляева Н. В., Лукашевич Г. М., Фоменко П. Г., Бережная Э. В., Рахметова В. С. Доказательная панкреатология 2017/2018 (обзор результатов исследований по хроническому панкреатиту и внешнесекреторной недостаточности поджелудочной железы). Вестник Клуба панкреатологов. 2018. № 2. С. 12–20.
2. Мудрые мысли о медицине и врачевании: изречения, афоризмы, цитаты / Авт. композиции Я. С. Циммерман: 4-е изд., доп. Москва: ГЭОТАР-Медиа, 2015. 256 с.
3. Abu-El-Haija M., Werlin S. L., Freeman A. J., Georgieva M., Jojkic-Pavkov D., Kalnins D., Kochavi B., Koot B. G. P., Van Biervliet S., Walkowiak J., Wilschanski M., Morinville V. D. Nutritional considerations in pediatric pancreatitis: a position paper from the NASPHAN Pancreas Committee and ESPHAN Cystic Fibrosis/Pancreas. J. Pediatr. Gastroenterol. Nutr. 2018. Vol. 67, No 1. P. 131–143.
4. Antonini F., Crippa S., Falconi M., Macarri G., Pezzilli R. Pancreatic enzyme replacement therapy after gastric resection: an update. Dig. Liver Dis. 2018. Vol. 50, No 1. P. 1–5.
5. Balaban D. V., Robu G., Zoican A., Ciochina M., Jinga M. Does fecal elastase correlate with EUS morphologic alterations of chronic pancreatitis? Pancreatology. 2018. Vol. 18, Iss. 4 (suppl.). P. S172.
6. Bang U. C., Watanabe T., Bendtsen F. The relationship between the use of statins and mortality, severity, and pancreatic cancer in Danish patients with chronic pancreatitis. Eur. J. Gastroenterol. Hepatol. 2018. Vol. 30, No 3. P. 346–351.
7. De La Iglesia-Garcia D., Vallejo-Senra N., Lopez-Lopez A., Prada-Ramallal G., Iglesias-Garcia J., Larino-Noia J., Nieto-Garcia L., Dominguez-Munoz J. E. Effect of pancreatic exocrine and endocrine insufficiency in cardiovascular events in patients with chronic pancreatitis (CP). A prospective cohort study. Pancreatology. 2018. Vol. 18, Iss. 4 (suppl.). P. S170–S171.
8. De La Iglesia-Garcia D., Huang W., Baston-Rey I., Calvino-Suarez C., Larino-Noia J., Iglesias-Garcia J., Shi N., Zhang X., Cai W., Moore D., Szatmary P., Nunes Q. M., Mukherjee R., Sum X., Singh V. K., Xia Q., Dominguez-Munoz J. E., Sutton R. Exocrine pancreatic insufficiency following acute pancreatitis: systematic review and meta-analysis. Pancreatology. 2018. Vol. 18, No 4 (Suppl.). P. S102.
9. Dominguez-Munoz J. E., Nieto-Garcia L., Lopez-Diaz J., Larino-Noia J., Abdulkader I., Iglesias-Garcia J. Impact of the treatment of pancreatic exocrine insufficiency on survival of patients with unresectable pancreatic cancer: a retrospective analysis. BMC Cancer. 2018. Vol. 18, No 1. P. 534.
10. Dominguez-Munoz J. E., Phillips M. Nutritional therapy in chronic pancreatitis. Gastroenterol. Clin. North Am. 2018. Vol. 47, No 1. P. 95–106.
11. Durie P., Baillargeon J.-D., Bouchard S., Donnellan F., Zepeda-Gomez S., Teshima C. Diagnosis and management of pancreatic exocrine insufficiency (PEI) in primary care: consensus guidance of a Canadian expert panel. Curr. Med. Res. Opin. 2018. Vol. 34, No 1. P. 25–33.
12. Ewald N., Bretzel R. G., Fantus I. G., et al. Pancreatin therapy in patients with insulin-treated diabetes mellitus and exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations. Results of a prospective multi-centre trial. Diabetes Metab. Res. Rev. 2007. Vol. 23. P. 386–391.
13. Ewald N., Hardt P., Andersen D. Pancreatogenic diabetes: peculiarities in diagnosis and treatment. Pancreatology. 2018. Vol. 18, No 4 (Suppl.). P. S39–S40.
14. Garah J., Rosen I., Shaoul R. Transient exocrine pancreatic insufficiency in children. J. Pediatr. Gastroenterol. Nutr. 2018. Vol. 66 (Suppl. 2). P. 257.
15. Gil C. V., Luque R. S., Viedma B. L., Portugues M. U., Munoz J. R., Rincon L. Role of faecal elastase in predicting echoendoscopic findings in chronic pancreatitis. Pancreatology. 2018. Vol. 18, Iss. 4 (suppl.). P. S111.
16. Hao L., Wang L. S., Liu Y., Wang T., Guo H. L., Pan J., Wang D., Bi Y. W., Ji J. T., Xin L., Du T. T., Lin J. H., Zhang D., Zeng X. P., Zou W. B., Chen H., Xie T., Li B. R., Liao Z., Cong Z. J., Xu Z. L., Li Z. S., Hu L. H. The different course of alcoholic and idiopathic chronic pancreatitis: a long-term study of 2,037 patients. PLoS ONE. 2018. Vol. 13, No 6. e0198365.
17. Khandelwal N., Wang S., Johns B., Vora J., Castelli-Haley J., Singh V. K. Economic impact of treatment adherence in exocrine pancreatic insufficiency (EPI) patients treated with pancreatic enzyme replacement therapy (PERT). Value in Health. 2018. Vol. 21 (Suppl.). P. S85–S86.
18. Knop F. K., Vilsboll T., Larsen S., et al. Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution. Am. J. Physiol. Endocrinol. Metab. 2007. Vol. 292. P. E324–E330.
19. Kondrashova A., Nurminen N., Lehtonen J., Hyoty M., Toppari J., Ilonen J., Veijola R., Knip M., Hyoty H. Exocrine pancreas function decreases during the progression of the beta-cell damaging process in young prediabetic children. Pediatric Diabetes. 2018. Vol. 19, No 3. P. 398–402.
20. Lee H. W., Moon S.-H., Kim M.-H., Cho D. H., Jun J. H., Nam K., Song T. J., Park D. H., Lee S. S., Seo D.-W., Lee S. K. Relapse rate and predictors of relapse in a large single center cohort of type 1 autoimmune pancreatitis: long-term follow-up results after steroid therapy with short-duration maintenance treatment. J. Gastroenterol. 2018. Vol. 53, No 8. P. 967–977.
21. Lindkvist B., Nilsson C., Kvarnström M., Oscarsson J. Importance of pancreatic exocrine dysfunction in patients with type 2 diabetes: a randomized crossover study. Pancreatology. Vol. 18. 2018. P. 550–558.
22. Machicado J. D., Chari S. T., Timmons L., Tang G., Yadav D. A population-based evaluation of the natural history of chronic pancreatitis. Pancreatology. 2018. Vol. 18, No 1. P. 39-45.
23. Masamune A., Kikuta K., Hamada S., Nakano E., Kume K., Inui A., Shimizu T., Takeyama Y., Nio M., Shimosegawa T. Nationwide survey of hereditary pancreatitis in Japan. J. Gastroenterol. 2018. Vol. 53, No 1. P. 152–160.
24. Milanetto A. C., Menato R., Lio V., Pedrazzoli S., Pasquali C. 35 years of distal pancreatectomy for neuroendocrine neoplasms in a single centre. Pancreatology. 2018. Vol. 18, Iss. 4 (Suppl.). P. S157.
25. Nayar M., Oppong K., Leeds J., Bekkali N., Tsang P. Does IGG4 level at the time of diagnosis correlate with outcome in IGG4-related disease? Gut. 2018. Vol. 67 (suppl.). P. A153.
26. Ni Chonchubhair H. M., Bashir Y., Dobson M., Ryan B. M., Duggan S. N., Conlon K. C. The prevalence of small intestinal bacterial overgrowth in non-surgical patients with chronic pancreatitis and pancreatic exocrine insufficiency (PEI). Pancreatology. 2018. Vol. 18, Iss. 4. P. 379–385.
27. Pongprasobchai S., Thanathanee P., Pausawasdi N., Prachayakul V., Leelakusolvong S., Tanwandee T. Clinical, radiological, and endosonographic features to predict severe pancreatic exocrine insufficiency in patients with chronic pancreatitis: a cross-sectional study. J. Med. Ass. Thailand. 2018. Vol. 101, No 5. P. 643–650.
28. Prasanna Kumar H. R., Basavana Gowdappa H., Tejashwi Hosmani, Tejashri Urs. Exocrine dysfunction correlates with endocrinal impairment of pancreas in type 2 diabetes mellitus. Indian J. Endocrinol. Metab. 2018. Vol. 22, No 1. P. 121–125.
29. Rosenfeld M., Wainwright C. E., Higgins M., Wang L. T., McKee C., Campbell D., Tian S., Schneider J., Cunningham S., Davies J. C., ARRIVAL study group. Ivacaftor treatment of cystic fibrosis in children aged 12 to <24 months and with a CFTR gating mutation (ARRIVAL): a phase 3 single-arm study. Lancet Respir. Med. 2018. Vol. 6, No 7. P. 545–553.
30. Ross J. J., Wasserfall C., Perry D. J., Mcgrail K. M., Posgai A. L., Brusko T. M., Schatz D., Haller M. J., Atkinson M. A., Ocala F. L., Gainesville F. L. Exocrine pancreatic function as a novel biomarker in pre-T1D. Diabetes. 2018. Vol. 67 (Suppl.). P. A412–A413.
31. Sheel A., Baron R., Ramesh J., Ghaneh P., Raraty M., Yip V., Sutton R., Campbell F., Farooq A., Halloran C., Neoptolemos J. Alcohol excess and continued smoking are risk factors for progression from minimal change chronic pancreatitis to established chronic pancreatitis. Pancreatology. 2018. Vol. 18, Iss. 4 (suppl.). P. S103–S104.
32. Suzumura K., Hatano E., Okada T., Asano Y., Uyama N., Nakamura I., Hai S., Fujimoto J. Short- and long-term outcomes of the Frey procedure for chronic pancreatitis: a single-center experience and summary of outcomes in Japan. Surgery Today. 2018. Vol. 48, No 1. P. 58–65.
33. Szentesi A., Toth E., Balint E., Fanczal J., Madacsy T., Laczko D., Ignath I., Balazs A., Pallagi P., Maleth J., Rakonczay Z. Jr., Kui B., Illes D., Marta K., Blasko A., Demcsak A., Parniczky A., Par G., Godi S., Mosztbacher D., Szucs A., Halasz A., Izbeki F., Farkas N., Hegyi P., Hungarian Pancreatic Study Group. Analysis of research activity in gastroenterology: pancreatitis is in real danger. PLoS One. 2016. Vol. 11, No 10. e0165244.
34. Tahtaci M., Koseoglu H., Alisik M., Tayfur Yurekli O., Tahtaci G., Erel O., Ersoy O. Association of low fecal elastase-1 and non-ulcer dyspepsia. J. Clin. Med. 2018. Vol. 7, No 6.
35. Talukdar R., Reddy D. N. Pancreatic exocrine insufficiency in type 1 and 2 diabetes: therapeutic implications. J. Assoc. Physicians India. 2017. Vol. 65, No 9. P. 64–70.
36. Tu J., Yang Y., Zhang J., Yang Q., Lu G., Li B., Tong Z., Ke L., Li W., Li J. Effect of the disease severity on the risk of developing new-onset diabetes after acute pancreatitis. Medicine. 2018. Vol. 97, No 22. P. e10713.
37. Vinokurova L., Baimakanova G., Krasovsky S., Silvestrova S., Varvanina G., Dubtsova E., Bordin D. Functional insufficiency of the pancreas and the metabolic activity of the microbiota in cystic fibrosis adults patients. Pancreatology. 2018. Vol. 18, Iss. 4 (suppl.). P. S54.
38. Wejnarska K., Kolodziejczyk E., Rygiel A. M., Bal J., Oracz G. Does the pancreas divisum reflect the clinical course of chronic pancreatitis in children? Pancreatology. 2018. Vol. 18, Iss. 4 (suppl.). P. S22.
39. Whitcomb D. C., Bodhani A., Beckmann K., et al. Efficacy and safety of pancrealipase/pancreatin in patients with exocrine pancreatic insufficiency and a medical history of diabetes mellitus. Pancreas. 2016. Vol. 45. P. 676–686.
40. Yilmaz A., Hagberg L. Exocrine pancreatic insufficiency is common in people living with HIV on effective antiretroviral therapy. Infectious Diseases. 2018. Vol. 50, No 3. P. 193–199.